BRIEF-Charles River Laboratories Provides Business Updates

Reuters01-13

BRIEF-Charles River Laboratories Provides Business Updates

Jan 12 (Reuters) - Charles River Laboratories International Inc CRL.N:

CHARLES RIVER LABORATORIES PROVIDES BUSINESS UPDATES
CHARLES RIVER LABORATORIES INTERNATIONAL INC: SIGNS AGREEMENT TO ACQUIRE K.F. (CAMBODIA) LTD. TO FURTHER STRENGTHEN DSA SUPPLY CHAIN
CHARLES RIVER LABORATORIES INTERNATIONAL - DEAL TO BE ACCRETIVE TO ADJUSTED EARNINGS PER SHARE BY ABOUT $0.25 IN 2026 AND APPROXIMATELY $0.60 IN 2027
CHARLES RIVER LABORATORIES INTERNATIONAL INC - PROPOSED ACQUISITION VALUED AT $510 MILLION
CHARLES RIVER LABORATORIES INTERNATIONAL INC - K.F. IS NOT EXPECTED TO GENERATE MEANINGFUL THIRD-PARTY REVENUE GOING FORWARD
CHARLES RIVER LABORATORIES INTERNATIONAL INC - TO BUY REMAINING 79% OF PATHOQUEST SAS
CHARLES RIVER LABORATORIES INTERNATIONAL INC - PATHOQUEST ACQUISITION VALUED AT €51.6 MILLION
CHARLES RIVER LABORATORIES INTERNATIONAL INC - PATHOQUEST IS EXPECTED TO GENERATE ANNUAL REVENUE OF ABOUT $15 TO $20 MILLION IN 2026
CHARLES RIVER LABORATORIES INTERNATIONAL - PATHOQUEST DEAL NOT EXPECTED TO HAVE MATERIAL IMPACT ON CHARLES RIVER'S 2026 OR 2027 FINANCIAL RESULTS
CHARLES RIVER LABORATORIES INTERNATIONAL: SEES TOP END OF GUIDANCE RANGE FOR 2026 ORGANIC REVENUE GROWTH WILL BE AT LEAST FLAT

Source text: ID:nBw4f4gPha

Further company coverage: CRL.N

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2603502529?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-13 05:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2603502529","market":"nz","top_or_hot":-1,"title":"BRIEF-Charles River Laboratories Provides Business Updates","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Charles River Laboratories Provides Business Updates</title></head><body><p><span>Jan 12 (Reuters)</span><span> - </span>Charles River Laboratories International Inc <span>CRL.N</span>:</p><ul><li><p>CHARLES RIVER LABORATORIES PROVIDES BUSINESS UPDATES</p></li><li><p>CHARLES RIVER LABORATORIES INTERNATIONAL INC: SIGNS AGREEMENT TO ACQUIRE <a href=\"https://laohu8.com/S/TKKD.SI\">K</a>.F. (CAMBODIA) LTD. TO FURTHER STRENGTHEN DSA SUPPLY CHAIN</p></li><li><p>CHARLES RIVER LABORATORIES INTERNATIONAL - DEAL TO BE ACCRETIVE TO ADJUSTED EARNINGS PER SHARE BY ABOUT $0.25 IN 2026 AND APPROXIMATELY $0.60 IN 2027</p></li><li><p>CHARLES RIVER LABORATORIES INTERNATIONAL INC - PROPOSED ACQUISITION VALUED AT $510 MILLION</p></li><li><p>CHARLES RIVER LABORATORIES INTERNATIONAL INC - K.F. IS NOT EXPECTED TO GENERATE MEANINGFUL THIRD-PARTY REVENUE GOING FORWARD</p></li><li><p>CHARLES RIVER LABORATORIES INTERNATIONAL INC - TO BUY REMAINING 79% OF PATHOQUEST SAS</p></li><li><p>CHARLES RIVER LABORATORIES INTERNATIONAL INC - PATHOQUEST ACQUISITION VALUED AT €51.6 MILLION</p></li><li><p>CHARLES RIVER LABORATORIES INTERNATIONAL INC - PATHOQUEST IS EXPECTED TO GENERATE ANNUAL REVENUE OF ABOUT $15 TO $20 MILLION IN 2026</p></li><li><p>CHARLES RIVER LABORATORIES INTERNATIONAL - PATHOQUEST DEAL NOT EXPECTED TO HAVE MATERIAL IMPACT ON CHARLES RIVER'S 2026 OR 2027 FINANCIAL RESULTS</p></li><li><p>CHARLES RIVER LABORATORIES INTERNATIONAL: SEES TOP END OF GUIDANCE RANGE FOR 2026 ORGANIC REVENUE GROWTH WILL BE AT LEAST FLAT</p></li></ul><p>Source text: <span>ID:nBw4f4gPha</span></p><p>Further company coverage: <span>CRL.N</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Charles River Laboratories Provides Business Updates</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Charles River Laboratories Provides Business Updates\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-01-13 05:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Charles River Laboratories Provides Business Updates</title></head><body><p><span>Jan 12 (Reuters)</span><span> - </span>Charles River Laboratories International Inc <span>CRL.N</span>:</p><ul><li><p>CHARLES RIVER LABORATORIES PROVIDES BUSINESS UPDATES</p></li><li><p>CHARLES RIVER LABORATORIES INTERNATIONAL INC: SIGNS AGREEMENT TO ACQUIRE <a href=\"https://laohu8.com/S/TKKD.SI\">K</a>.F. (CAMBODIA) LTD. TO FURTHER STRENGTHEN DSA SUPPLY CHAIN</p></li><li><p>CHARLES RIVER LABORATORIES INTERNATIONAL - DEAL TO BE ACCRETIVE TO ADJUSTED EARNINGS PER SHARE BY ABOUT $0.25 IN 2026 AND APPROXIMATELY $0.60 IN 2027</p></li><li><p>CHARLES RIVER LABORATORIES INTERNATIONAL INC - PROPOSED ACQUISITION VALUED AT $510 MILLION</p></li><li><p>CHARLES RIVER LABORATORIES INTERNATIONAL INC - K.F. IS NOT EXPECTED TO GENERATE MEANINGFUL THIRD-PARTY REVENUE GOING FORWARD</p></li><li><p>CHARLES RIVER LABORATORIES INTERNATIONAL INC - TO BUY REMAINING 79% OF PATHOQUEST SAS</p></li><li><p>CHARLES RIVER LABORATORIES INTERNATIONAL INC - PATHOQUEST ACQUISITION VALUED AT €51.6 MILLION</p></li><li><p>CHARLES RIVER LABORATORIES INTERNATIONAL INC - PATHOQUEST IS EXPECTED TO GENERATE ANNUAL REVENUE OF ABOUT $15 TO $20 MILLION IN 2026</p></li><li><p>CHARLES RIVER LABORATORIES INTERNATIONAL - PATHOQUEST DEAL NOT EXPECTED TO HAVE MATERIAL IMPACT ON CHARLES RIVER'S 2026 OR 2027 FINANCIAL RESULTS</p></li><li><p>CHARLES RIVER LABORATORIES INTERNATIONAL: SEES TOP END OF GUIDANCE RANGE FOR 2026 ORGANIC REVENUE GROWTH WILL BE AT LEAST FLAT</p></li></ul><p>Source text: <span>ID:nBw4f4gPha</span></p><p>Further company coverage: <span>CRL.N</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0029874061.USD","symbol_name":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" YDIS INC","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUA7D6FYZ:1","article_id":"2603502529","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2603502529","pubTimestamp":1768254210,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Charles River Laboratories Provides Business UpdatesJan 12 (Reuters) - Charles River Laboratories International Inc CRL.N:CHARLES RIVER LABORATORIES PROVIDES BUSINESS UPDATESCHARLES RIVER LABORA","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0029874061.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" YDIS INC","BK4588":"碎股","LU0390134368.USD":"FRANKLIN GLOBAL GROWTH \"A\" (USD) ACC","LU0757428866.USD":"THREADNEEDLE (LUX) GLOBAL SMALLER COMPANIES \"AE\" (USD) ACC","BK4585":"ETF&股票定投概念","IE00BFMHRM44.USD":"NEUBERGER BERMAN GLOBAL EQUITY MEGATRENDS \"A\" (USD) ACC","LU1815336091.USD":"THREADNEEDLE (LUX) GLOBAL SMALLER COMPANIES \"AUP\" (USD) INC","BK4121":"生命科学工具和服务","CRL":"查尔斯河","BK4530":"医药外包概念","LU0128526141.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" ACC"},"translate_title":"简介-查尔斯河实验室提供业务更新","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CRL":0.9},"content_text":"BRIEF-Charles River Laboratories Provides Business UpdatesJan 12 (Reuters) - Charles River Laboratories International Inc CRL.N:CHARLES RIVER LABORATORIES PROVIDES BUSINESS UPDATESCHARLES RIVER LABORATORIES INTERNATIONAL INC: SIGNS AGREEMENT TO ACQUIRE K.F. (CAMBODIA) LTD. TO FURTHER STRENGTHEN DSA SUPPLY CHAINCHARLES RIVER LABORATORIES INTERNATIONAL - DEAL TO BE ACCRETIVE TO ADJUSTED EARNINGS PER SHARE BY ABOUT $0.25 IN 2026 AND APPROXIMATELY $0.60 IN 2027CHARLES RIVER LABORATORIES INTERNATIONAL INC - PROPOSED ACQUISITION VALUED AT $510 MILLIONCHARLES RIVER LABORATORIES INTERNATIONAL INC - K.F. IS NOT EXPECTED TO GENERATE MEANINGFUL THIRD-PARTY REVENUE GOING FORWARDCHARLES RIVER LABORATORIES INTERNATIONAL INC - TO BUY REMAINING 79% OF PATHOQUEST SASCHARLES RIVER LABORATORIES INTERNATIONAL INC - PATHOQUEST ACQUISITION VALUED AT €51.6 MILLIONCHARLES RIVER LABORATORIES INTERNATIONAL INC - PATHOQUEST IS EXPECTED TO GENERATE ANNUAL REVENUE OF ABOUT $15 TO $20 MILLION IN 2026CHARLES RIVER LABORATORIES INTERNATIONAL - PATHOQUEST DEAL NOT EXPECTED TO HAVE MATERIAL IMPACT ON CHARLES RIVER'S 2026 OR 2027 FINANCIAL RESULTSCHARLES RIVER LABORATORIES INTERNATIONAL: SEES TOP END OF GUIDANCE RANGE FOR 2026 ORGANIC REVENUE GROWTH WILL BE AT LEAST FLATSource text: ID:nBw4f4gPhaFurther company coverage: CRL.N ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.1","shortVersion":"4.36.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2603502529","isCrawlerRequest":true}